New Frontiers in Ophthalmology is the annual meeting of the Research Foundation. First held in 2013, it has developed to become a seminal event in the educational calendar.
Hosting key international speakers, New Frontiers in Ophthalmology is at the forefront of education in the diverse field of Ophthalmology. Topics range from Corneal Stem Cell and Tissue Engineering, Diabetic Retinopathy, Glaucoma, Ocular Oncology and Paediatric Ophthalmology.
Attendees have the opportunity to engage with experts and learn of the latest developments in their field. New Frontiers in Ophthalmology is recognised by the Irish College for Ophthalmologists for 4 CPD credits.
VII New Frontiers in Ophthalmology Meeting
‘Paedriatric Ophthalmology & Strabismus’
9.30 – 13.00, Thursday 20th June 2019, Education & Conference Centre, Royal Victoria Eye & Ear Hospital
Registration opens 8.30am, Refreshments & Lunch are provided
We are delighted to announce Speakers at this year’s meeting are:
Mr. Joe Abbot, Birmingham Women’s and Children’s Hospital
Ms. Arundhati Dev Borman, Great Ormond Street Hospital
Mr. Stephen Farrell, Temple Street Children’s Hospital & MMUH
Mr. Ian Flitcroft, Temple Street Children’s Hospital & MMUH
Mr. Ian Marsh, University Hospital Aintree
New Frontiers in Ophthalmology is followed in the afternoon by the annual Eithne Walls Research Meeting.
Registration is now Closed
If you require accommodation, New Frontiers in Ophthalmology attendees can avail of a special delegate rate at The Wilder Hotel, conveniently located just opposite the Royal Victoria Eye & Ear Hospital on Adelaide Road.
Call +353 (0)1 969 65 98 to make your booking. and ensure you mention ‘New Frontiers Meeting’.
This meeting is kindly sponsored by
The 2018 New Frontiers in Ophthalmology took place on Thursday 7th June.
Always an important event in the calendar year, this year’s meeting again played host to expert speakers and international colleagues, focusing on advances in Ocular Inflammation
- Dr John Fitzsimons (Our Lady of Lourdes Hospital, Drogheda)
Advances in the Diagnosis and Management of Allergy
- Mr Barry Quill (Royal Victoria Eye & Ear Hospital)
Update on Ocular Allergy
- Dr Monica Berry (University of Bristol)
Molecular chat: mucins, sugars and cells
- Athanasios Vardarinos
Evidence on treat and extend Ranibizumab continues to build. Review of the RIVAL interim results and real-world outcomes
- Prof Elizabeth Vandenberghe (St James’s Hospital)
The challenge of managing ocular Graft versus Host disease post stem cell transplantation
- Professor Friedrich Kruse (University of Erlangen, Germany)
New frontiers in ocular surface disorders
- Professor John Crown, Consultant Medical Oncologist, St Vincents University Hospital, Dublin‘Drug Therapy of Ocular Melanoma’
- Professor Giuseppe Gullo, Consultant Medical Oncologist, St Vincents University Hospital, Dublin‘Survival in Uveal Melanoma: An Irish Patient Cohort’
- Dr. Arun Singh MD Cole Eye Institute Cleveland, Ohio, US‘Diagnosis of Uveal Melanoma – Pearls and Pitfalls’
- Dr. Arun Singh MD Cole Eye Institute Cleveland, Ohio, US‘Genetics of Uveal Melanoma – Recent Advances’
- Dr Paul Kenna, Director of Research, Royal Victoria Eye & Ear Research Foundation‘Inherited Retinal Degenerations – From Cause to ? Cure’
- Dr Sinead Connolly, Clinical Educator and Research Fellow, Royal College of Surgeons in Ireland‘Small Molecules with Big Potential – Nanoparticle Approaches in Ophthalmology’
Glaucoma Study Day
The meeting was chaired by Ms Aoife Doyle (Royal Victoria Eye & Ear Hospital).
- Prof Anthony J.W King (Nottingham University Hospital)
- Mr Jeremy O’Connor (Royal Victoria Eye & Ear Hospital)
- Yvonne Delaney (Bons Secour Hospital)
- Prof Colm O’Brien (Mater Misericordiae University Hospital)
- Ms Carol Hoang (Novartis Global Brand Medical Director)
- Prof Anthony King, Consultant Ophthalmic Surgeon, Honorary Clinical Professor of Ophthalmology, Nottingham University Hospital Surgery as initial intervention for advanced glaucoma
- Mr Jeremy O’Connor, Consultant Ophthalmic Surgeon, Royal Victoria Eye & Ear Hospital MIGS
The New Frontiers in Ophthalmology Meeting was held on Thursday 12th June 2014 in the Education and Conference Centre of the Royal Victoria Eye & Ear Hospital.
- Lloyd Paul Aiello (Harvard University)
- Mr Mark Cahill (Royal Victoria Eye & Ear Hospital)
- Dr Reinhold Medina (Queens University Belfast)
- Mr David Keegan (Mater Misericordiae University Hospital & Mater Private Hospital))
- Mr Rob Acheson (Mater Private Hospital))
The meeting was sponsored by Novartis. The meeting had a excellent turnout and we received very positive feedback. We would like to thank the speakers Mr Mark Cahill (Chair), Prof Lloyd Paul Aiello, Dr Reinhold Medina, Mr David Keegan and Mr Rob Acheson and in particular Novartis for making the meeting such a great success.
- Lloyd Paul Aiello, MD, PhD, Professor of Ophthalmology, Harvard University Journey to the Edge of the Retina / Journey through the Depths of the Retina
- Mark Cahill, Clinical Lead, Global Vision, Royal Victoria Eye and Ear Hospital Diabetic Retina Screen Photography and Grading : Why, Where and How (it’s done)
- Reinhold Medina, M.D. Ph.D. Centre for Experimental Medicine Medicine, Dentistry & Biomedical Science, Queen’s University Belfast Potential Uses for Endothelial Progenitors in Diabetic Retinopathy
- David Keegan, PhD FRCOphth FRCSI(Oph) National Clinical Lead for Diabetic Retinopathy Transition to a National Diabetic Retinopathy Screening and Treatment Programme
- Robert Acheson, Clinical Lead, Mater Misericordiae University Hospital & Mater Private Hospital Diabetic Retina Screen – Arbitration and Gatekeeping
Corneal Stem Cell and Tissue Engineering.
The New Frontiers in Ophthalmology Meeting took place on Thursday 27th June 2013 in the Education & Conference Centre at the Royal Victoria Eye & Ear Hospital.
The morning of the meeting was devoted to a symposium on corneal stem cell and tissue engineering. The use of cell-based therapies in the management of ocular surface and corneal disorders is a new and rapidly evolving field with many potential disease applications. In this symposium the advances in the development of such therapies to restore the epithelial and endothelial corneal surfaces and the potential to transfer of these developments to the clinical setting were discussed.
- Prof Conor Murphy (Royal Victoria Eye and Ear Hospital)
- Mr Billy Power (Royal Victoria Eye and Ear Hospital)
- Dr Clair Gallagher (National Institute of Cellular Biotechnology, Dublin City University)
- Dr Finbarr O’Sullivan (National Institute of Cellular Biotechnology, Dublin City University)
- Prof Fergal O’Brien (Tissue Engineering Research Group, Royal College of Surgeons in Ireland)
- Dr Andrew Cameron (Tissue Engineering Research Group, Royal College of Surgeons in Ireland)
- Dr Kevin Kavanagh (NUI Maynooth)
- Sinead Masterson (Irish Medicines Board)
The afternoon was devoted to the Eithne Walls Research Meeting, at which NCHDs presented their latest research in competition for the Eithne Walls Medal and the Research Foundation Clinical Prize.
The meeting was well attended and supported by a unrestricted educational grant from Novartis.